相关实验视频
Updated: Jun 10, 2025

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
308
儿科肥胖药疗:科学现状,研究缺口和机遇
Sarah C Armstrong1,2,3, Ihuoma Eneli4, Stavroula K Osganian5
1Departments of Pediatrics.
Pediatrics
|October 11, 2024
概括
儿童肥胖是一个越来越令人担忧的问题. 专家建议将生活方式的改变与治疗青少年肥胖的药物相结合,但需要更多关于长期安全性和有效治疗策略的研究.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 公共卫生 公共卫生
- 药理疗研究 药理疗研究
背景情况:
- 儿童肥胖影响了近20%的美国儿童和青少年,构成了重大的公共卫生挑战.
- 最近的指导方针建议在医学上适用的情况下将生活方式干预与药物治疗结合起来.
- 对抗肥胖药物的使用和长期安全性在成长中的年轻人存在有限的证据.
研究的目的:
- 识别儿童肥胖症药物治疗的知识差距和研究机会.
- 为肥胖儿童和青少年提供最佳和公平的医疗管理策略.
主要方法:
- 国家糖尿病和消化和脏疾病研究所赞助的一次研讨会召集了肥胖,药物治疗和临床试验方面的专家.
- 讨论包括临床试验设计,药物使用指南,结果测量和护理交付.
- 青少年患者和护理人员分享了生活经验和研究需求.
主要成果:
- 确定了儿童肥胖药物治疗临床试验设计中的关键缺陷.
- 强调需要对儿童和青少年药物使用提供更明确的指导.
- 强调研究的重要性超越基于体重的结果和改善护理服务.
结论:
- 进一步的研究是必要的,以建立基于证据的指导方针,用于药物治疗儿科肥胖症.
- 解决研究缺口将支持开发安全,有效和公平的治疗方法.
- 整合专家和患者的观点对于推进儿科肥胖管理至关重要.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
701
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
701
Obesity
388
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
388
Analysis of Population Pharmacokinetic Data
237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Model Approaches for Pharmacokinetic Data: Physiological Models
35
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
35
Diabetes: Management and Pharmacotherapy
238
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
238

